Clinical trials
Terminated Neoplasm Metastasis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
398 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2002 | 6 |
| 2003 | 5 |
| 2004 | 9 |
| 2005 | 23 |
| 2006 | 10 |
| 2007 | 11 |
| 2008 | 16 |
| 2009 | 22 |
| 2010 | 16 |
| 2011 | 20 |
| 2012 | 20 |
| 2013 | 20 |
| 2014 | 19 |
| 2015 | 12 |
| 2016 | 13 |
| 2017 | 23 |
| 2018 | 18 |
| 2019 | 26 |
| 2020 | 20 |
| 2021 | 36 |
| 2022 | 18 |
| 2023 | 15 |
| 2024 | 7 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 398 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 23 |
| M.D. Anderson Cancer Center | 21 |
| Pfizer | 13 |
| Novartis Pharmaceuticals | 9 |
| H. Lee Moffitt Cancer Center and Research Institute | 7 |
| Duke University | 6 |
| Incyte Corporation | 6 |
| University of Wisconsin, Madison | 6 |
| Eli Lilly and Company | 5 |
| Clovis Oncology, Inc. | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 398 |
| Neoplasms | 82 |
| Carcinoma, Non-Small-Cell Lung | 60 |
| Breast Neoplasms | 58 |
| Melanoma | 57 |
| Colorectal Neoplasms | 48 |
| Lung Neoplasms | 46 |
| Recurrence | 37 |
| Prostatic Neoplasms | 31 |
| Carcinoma, Renal Cell | 30 |
Trials
Showing 1 to 25 of 398. Each trial links to its page on Pharma Observatory.
298 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.